Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imatinib as a potential antiresorptive therapy for bone disease.
Dewar AL, Farrugia AN, Condina MR, Bik To L, Hughes TP, Vernon-Roberts B, Zannettino AC. Dewar AL, et al. Among authors: zannettino ac. Blood. 2006 Jun 1;107(11):4334-7. doi: 10.1182/blood-2005-09-3568. Epub 2006 Jan 31. Blood. 2006. PMID: 16449525 Free article.
OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib.
White DL, Saunders VA, Dang P, Engler J, Zannettino AC, Cambareri AC, Quinn SR, Manley PW, Hughes TP. White DL, et al. Among authors: zannettino ac. Blood. 2006 Jul 15;108(2):697-704. doi: 10.1182/blood-2005-11-4687. Epub 2006 Apr 4. Blood. 2006. PMID: 16597591 Free article.
Long-term imatinib therapy promotes bone formation in CML patients.
Fitter S, Dewar AL, Kostakis P, To LB, Hughes TP, Roberts MM, Lynch K, Vernon-Roberts B, Zannettino AC. Fitter S, et al. Among authors: zannettino ac. Blood. 2008 Mar 1;111(5):2538-47. doi: 10.1182/blood-2007-07-104281. Epub 2007 Nov 27. Blood. 2008. PMID: 18042796 Free article.
Imatinib mesylate causes growth plate closure in vivo.
Vandyke K, Dewar AL, Fitter S, Menicanin D, To LB, Hughes TP, Zannettino AC. Vandyke K, et al. Among authors: zannettino ac. Leukemia. 2009 Nov;23(11):2155-9. doi: 10.1038/leu.2009.150. Epub 2009 Jul 23. Leukemia. 2009. PMID: 19626049 No abstract available.
Dysregulation of bone remodeling by imatinib mesylate.
Vandyke K, Fitter S, Dewar AL, Hughes TP, Zannettino AC. Vandyke K, et al. Among authors: zannettino ac. Blood. 2010 Jan 28;115(4):766-74. doi: 10.1182/blood-2009-08-237404. Epub 2009 Nov 4. Blood. 2010. PMID: 19890095 Free article. Review.
220 results